focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Desparado!
Correction: Sorry - H2 -2019 for Belluscura
In the same way that most of us have capital tied up in TEK shares, I wonder if or how many IP investment opportunities have passed by TEK whilst they attempt to commercialise their investments in Lucyd, Belluscura, Salarius and Guident.
I hope to be proved wrong but if the sales figures in the 2019 accounts for Lucyd are poor and we're then 3/4 of the way through the 2020 financial year, I genuinely believe that they should call time. They've thrown a lot of money at it.
With regards to Belluscura, the constant delays (H1 2019 being the first announcement) cause me some concern. To be so far out on your expected approval date makes you question their capability. Those same delays have cost us dearly in terms of dilution.
Another one bites the dust. Good news will prob take it back to levels a month or so ago.
Couldn't agree more BigBang. Been holding here for over 3 years, and will continue to do so as there are massive inflection points due, it's just a question of patience.
GLA.
I think the way the SP is dropping like a stone, any BOD with half a brain cell between them would be doing their best to shore up the SP with some decent news that is if there is any. Not asking for a made up story just a taste of how well these major salt deals are progressing or the results of the clinical trial. There'd be more chance of getting the results from the woman who conducted the trial than TEK at the moment. Feel free to give her a shout on LinkedIn Elvira Cawthon. A bottle of wine, bunch of flowers and a nice dinner and she might give us a bit of an update on whether the trial was a success or not.
Thanks for your thoughts on the leadership team BigBang. Certainly on paper their expertise looks unquestionable. So as mentioned by others, we need somebody to drive their ideas forwards into commercial success.
I am hoping Belluscura is just a matter of time. I say this, as while I won't profess to be an expert on oxygen equipment, they don't sound like they are trying to re-invent the wheel.....it is just a smaller, more portable (cost efficient) version of existing technology. So as long as it is properly made/reliable and can be simply assembled then I would expect it to get approval (hopefully soon). The market for this equipment is already large and developed countries have an aging population, so COVID or not this looks a good longterm opportunity.
Salarius is enough to keep most investors interested at this share price.
Guident looks like a work of genius but may be a while to it generates income (unless a big player swoops in).
Lucyd looks technology that would have existed in Japan or South Korea ten years ago (and didn't take off)...but perhaps the improved sound quality etc may make it a success (it would be a nice surprise if it did…not holding my breath on this one).
I know it’s very frustrating. I suspect they thought the FDA approval was just a forgone conclusion in a boffin type of mindset! Probably in hindsight it would have been better to employ a company used to dealing with the FDA to help them?
Not going to give too much away about my background, but spent 30+ years assessing thousands of business propositions for finance. At the end of the day, I found the most important thing was a person’s character. A few years back I attended the TEK AGM, not to listen to all the figures, but just to assess this very point for myself. There is absolutely no doubt in my mind that Cliff and the guys around him are top notch and honest as the day is long.
Perhaps, Lucyd was the only one where, because of the son’s involvement, judgement may be a little clouded, but I suppose if he is going to take TEKs reins at some point in the future, the dad thinks it’s a good grooming exercise?
The Belluscura delay is annoying, but think to myself, even if it had been approved in June I would be still holding on for Salarius…so in my mind it doesn’t matter if the price is 12p or 30p, I would be still holding my position…having said this, a success of one of the companies would be settling, also I didn’t always get every propositions right!!…there is a risk, but if there wasn’t, the share price would be considerably higher!!!…anyway off out for the rest of the day GLA
Totally agree BingBang, I'm just a bit vexed with how Belluscura has played out again and was hoping we could have found a new support level nearer 20p rather than treading water close to single digits.
Hum..not so sure on that and I think it’s different, although same outcome! I’ve been investing in AIM companies for decades and the salaries are not huge compared with some. Certainly, I’ve been invested in others where the salaries are silly compared with profit.
My own personal feeling is that it’s a more Bill Gates type thing!!! Most of the people at the top here are not young upstarts, but have had long and successful careers and have enough money. Probably living in oversized homes after their children have left, probably on huge company/university pensions, so my theory is that it not a money thing. More like they are involved in these companies ‘for the good of mankind to make the world a better place’ and that is their main goal? Still think they will get there, will be worthwhile for the shareholders but it seems to be lacking that killer sense of urgency to get things done asap.
Anyway, that’s my silly theory…still think patience will be well rewarded!
Look at a 5 year chart.
Suffering? Are you suggesting that Belluscura never applied for FDA approval, that salarius aren't actually making salt, that Guident didn't win the Florida Atlantic University (FAU) Tech Runway® Annual tech Launch competition or that Lucyd aren't selling glasses on the market place?
sure the news is slow and it's never great to see an investment go down but I wouldn't say anyone here is suffering as we know there is news on the horizon.
Very poor show here, we've been strung along once again, how many times are Belluscura going to move the goal post ? When will Cliff be rattling the tin again to pay all the wages at the ip companies ? All at the expense of the long suffering TEK shareholders who will be faced with more dilution.